Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
Solomon Tesfaye(Sheffield Teaching Hospitals NHS Foundation Trust), Andrew J.M. Boulton(University of Manchester), Peter James Dyck(Mayo Clinic), Roy Freeman(Beth Israel Deaconess Medical Center), Michael Horowitz(The University of Adelaide), Péter Kempler(Semmelweis University), Giuseppe Lauria(Fondazione IRCCS Istituto Neurologico Carlo Besta), Rayaz A. Malik(University of Manchester), Vincenza Spallone(University of Rome Tor Vergata), Aaron I. Vinik(Eastern Virginia Medical School), Luciano Bernardi(University of Pavia), Paul Valensi(Hôpital Jean-Verdier), on behalf of the Toronto Diabetic Neuropathy Expert Group
Cited by 2,623Open Access
Abstract
Preceding the joint meeting of the 19th annual Diabetic Neuropathy Study Group of the European Association for the Study of Diabetes (NEURODIAB) and the 8th International Symposium on Diabetic Neuropathy in Toronto, Canada, 13-18 October 2009, expert panels were convened to provide updates on classification, definitions, diagnostic criteria, and treatments of diabetic peripheral neuropathies (DPNs), autonomic neuropathy, painful DPNs, and structural alterations in DPNs.
Related Papers
No related papers found
Powered by citation graph analysis